Richard Fajzel

Guest Contributor
March 4, 2016

Richard Fajzel has been appointed board chair of CQDM, a consortium of pharmaceutical firms that funds early-stage research for tools and technologies that accelerate drug discovery. Fajzel is VP business development at Exactis Innovation, a non-profit organization dedicated to improving cancer survivorship through innovation funded by the Networks of Centres of Excellence program. He spent 25 years at Pfizer in senior management roles including GM of the Canadian oncology unit and senior director US oncology accounts. Fajzel replaces Leon Gosselin who has retired….

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies.
We use cookies to provide you with a great experience and to help our website run effectively
in accordance with our Privacy Policy and Terms of Service.